Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dubsky

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Breast (Edinburgh, Scotland)|January 20, 2023
The underused potential of breast conserving therapy after neoadjuvant system treatment - Causes and solutionsAndré Pfob, Peter Dubsky
The Lancet. Oncology|June 19, 2012
Bisphosphonates in early breast cancerPeter Dubsky, Rupert Bartsch
European Journal of Cancer (Oxford, England : 1990)|January 4, 2021
Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by Pfob et alPeter Dubsky, Christoph Tausch
The Lancet. Oncology|May 4, 2010
Closing in on the unknown enemyMichael Gnant, Peter Dubsky
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
Bisphosphonates: prevention of bone metastases in breast cancerMichael Gnant, Peter Dubsky, Peyman Hadji
Breast Care (Basel, Switzerland)|June 20, 2014
Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?Michael Knauer, Martin Filipits, Peter Dubsky
Annals of Surgical Oncology|August 16, 2019
ASO Author Reflections: A Call for Surgeon Experience and Surgical Radicality to Prevent Residual Breast Tissue After Skin- and Nipple-Sparing MastectomyBärbel Papassotiropoulos, Uwe Güth, Peter Dubsky, et al.
European Radiology|January 26, 2024
Breast cancer: evaluating the axilla before, during, and after therapy-new challengesPetra Steyerova, Orit Kaidar-Person, Katja Pinker, et al.
Hematology/Oncology Clinics of North America|June 10, 2006
Dendritic cell-based vaccination against cancerHiroaki Saito, Davor Frleta, Peter Dubsky, et al.
Future Oncology (London, England)|February 25, 2014
New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?Peter Birner, Rupert Bartsch, Martin Schreiber, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Breast (Edinburgh, Scotland)|January 20, 2023
The underused potential of breast conserving therapy after neoadjuvant system treatment - Causes and solutionsAndré Pfob, Peter Dubsky
The Lancet. Oncology|June 19, 2012
Bisphosphonates in early breast cancerPeter Dubsky, Rupert Bartsch
European Journal of Cancer (Oxford, England : 1990)|January 4, 2021
Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by Pfob et alPeter Dubsky, Christoph Tausch
The Lancet. Oncology|May 4, 2010
Closing in on the unknown enemyMichael Gnant, Peter Dubsky
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
Bisphosphonates: prevention of bone metastases in breast cancerMichael Gnant, Peter Dubsky, Peyman Hadji
Breast Care (Basel, Switzerland)|June 20, 2014
Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?Michael Knauer, Martin Filipits, Peter Dubsky
Annals of Surgical Oncology|August 16, 2019
ASO Author Reflections: A Call for Surgeon Experience and Surgical Radicality to Prevent Residual Breast Tissue After Skin- and Nipple-Sparing MastectomyBärbel Papassotiropoulos, Uwe Güth, Peter Dubsky, et al.
European Radiology|January 26, 2024
Breast cancer: evaluating the axilla before, during, and after therapy-new challengesPetra Steyerova, Orit Kaidar-Person, Katja Pinker, et al.
Hematology/Oncology Clinics of North America|June 10, 2006
Dendritic cell-based vaccination against cancerHiroaki Saito, Davor Frleta, Peter Dubsky, et al.
Future Oncology (London, England)|February 25, 2014
New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?Peter Birner, Rupert Bartsch, Martin Schreiber, et al.
Pageof 10